Pages that link to "Q47567886"

The following pages link to Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function. (Q47567886):

Displaying 24 items.

• Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy (Q26771451) (← links)
• Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response (Q28078893) (← links)
• Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4. (Q33908836) (← links)
• IL-17B activated mesenchymal stem cells enhance proliferation and migration of gastric cancer cells (Q37745880) (← links)
• Interferon γ induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells (Q38685203) (← links)
• Unlocking the Potential of Purinergic Signaling in Transplantation (Q38785475) (← links)
• Immunomodulatory Properties of Induced Pluripotent Stem Cell-Derived Mesenchymal Cells. (Q38868645) (← links)
• Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration (Q42011447) (← links)
• Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile. (Q42204174) (← links)
• Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease. (Q42211281) (← links)
• Transcriptome Profiling of IL-17A Preactivated Mesenchymal Stem Cells: A Comparative Study to Unmodified and IFN-γ Modified Mesenchymal Stem Cells (Q42278117) (← links)
• Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials. (Q42689394) (← links)
• Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning? (Q47147635) (← links)
• Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis (Q47171663) (← links)
• Advances in mesenchymal stromal cell therapy in the management of Crohn's disease. (Q47287228) (← links)
• Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis. (Q52802494) (← links)
• Immunomodulatory effects of mesenchymal stromal cells-derived exosome. (Q53989481) (← links)
• IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis. (Q55071045) (← links)
• Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis. (Q55096337) (← links)
• Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies (Q64072329) (← links)
• Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery (Q89769517) (← links)
• Aggregation of Human Mesenchymal Stromal Cells Eliminates Their Ability to Suppress Human T Cells (Q90218840) (← links)
• Conditioned Serum Enhances the Chondrogenic and Immunomodulatory Behavior of Mesenchymal Stem Cells (Q91970783) (← links)
• Modulation of the Inflammatory Response and Bone Healing (Q97520988) (← links)